Beijing Tong Ren Tang Chinese Medicine Company Limited
HKSE 3613.HK
Beijing Tong Ren Tang Chinese Medicine Company Limited Shareholders' Equity for the year ending December 31, 2023: USD 495.03 M
-
Beijing Tong Ren Tang Chinese Medicine Company Limited Shareholders' Equity for the year ending December 31, 2022 was USD 461.41 M, a 5.27% change year over year.
-
Beijing Tong Ren Tang Chinese Medicine Company Limited Shareholders' Equity for the year ending December 31, 2021 was USD 438.31 M, a 12.65% change year over year.
-
Beijing Tong Ren Tang Chinese Medicine Company Limited Shareholders' Equity for the year ending December 31, 2020 was USD 389.11 M, a 14.02% change year over year.
-
Beijing Tong Ren Tang Chinese Medicine Company Limited Shareholders' Equity for the year ending December 31, 2019 was USD 341.27 M, a -7.99% change year over year.
| Date | Shareholders' Equity | Minority Interest | Total Equity | Total Stockholders Equity and Liabilities |
|---|
Don’t Miss A Beat
| CEO | Mr. Wang Chi |
| IPO Date | May 7, 2013 |
| Location | Hong Kong |
| Headquarters | Office Tower |
| Employees | 779 |
| Sector | Consumer Staples |
| Industries | |
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates 23 retail outlets in Hong Kong and 46 retail outlets in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand. The company was founded in 1669 and is based in Wan Chai, Hong Kong.
Past 5 years
USD 2.28
USD 0.63
USD 0.67
StockViz Staff
January 31, 2025
Any question? Send us an email